Yes.
AI Overview
View attachment 224127
View attachment 224128
View attachment 224129
View attachment 224130
Several Garmin watches have received FDA approval for their ECG (electrocardiogram) feature, which allows users to detect signs of atrial fibrillation (AFib). The Garmin Venu 2 Plus was the first, and now the
Venu 3,
Epix Pro (Gen 2),
Fenix 7 Pro, and
tactix 7 AMOLED edition also offer this capability. These watches use a 30-second reading to detect AFib and a normal sinus rhythm, and the results can be viewed on the watch or exported to the Garmin Connect app for sharing with healthcare providers.
Here's a more detailed breakdown:
- Garmin Venu 2 Plus:
The first Garmin watch to receive FDA approval for its ECG feature, enabling on-demand ECG recordings.
- Garmin Venu 3:
This model, along with the Epix Pro (Gen 2), Fenix 7 Pro, and tactix 7 AMOLED edition, also received FDA approval and ECG functionality.
- How it works:
The ECG app on these watches allows users to take a 30-second ECG reading by touching the watch's bezel with a finger from the opposite hand.
- FDA Approval and Availability:
The ECG feature is FDA-cleared and clinically validated, but its availability may vary by country. For example, in the US, users can utilize the ECG app, but it's not available worldwide.
- Benefits:
The ECG feature helps users monitor their heart rhythm and potentially identify signs of AFib, a common heart rhythm abnormality that can increase the risk of stroke.